Objective: To summarize the clinical and scientific evidence for commercially available ECG-based signal analysis technologies used or proposed to be used to evaluate patients at low to intermediate risk of coronary artery disease (CAD) who have chest pain or other symptoms suggestive of acute coronary syndrome (ACS).
